Metal Stent Market size is expected to be valuated at USD 5.6 Billion by 2035; Rising Demand for Minimally Invasive Treatments to Drive Market Growth

Download Sample

Published Date: September 2025

Metal stents are tiny mesh tubes inserted into constricted vessels, ducts, or cavities of the body in order to keep them open. They are majorly applied to the vascular system, especially in coronary arteries. Cardiovascular and chronic diseases and their prevalence, minimally invasive procedures, and hybrid stent design developments are some of the drivers that cause a rising metal stent market. Such opportunities in the future involve the creation of bioabsorbable stents, smart stents with implanted sensors, and new-generation coatings or drug-eluting technologies. There is also the possibility of growth in the emergent markets.

Segmentation Analysis:

By Type	Bare Metal Stents (BMS), Drug-Eluting Stents (DES), Grafted Stents, Others
By Material	Stainless Steel, Cobalt-Chromium Alloy, Platinum-Chromium Alloy, Nitinol (Nickel-Titanium Alloy), and Others
By Coating material	Biodegradable, Durable Polymers, Polymer-Free, Dual-Drug Coatings, and Others
By Mechanism	Balloon-Expandable, Self-Expanding, Hybrid (Partially Self-Expanding), and Others
By Application	Coronary Stents, Peripheral Vascular Stents, Carotid Stents, Renal Artery Stents, Aortic Stents, and Others
By Distribution Channel	Hospitals, Cardiac Catheterization Labs, Outpatient Surgery Centers, and Others

Report Highlights:

Metal stents market size is valuated at USD 3.8 Billion in 2025.
Target market size is estimated to be valuated at USD 5.6 Billion by 2035 and at a CAGR of 4.6%.
Drug-eluting stents hold the largest metal stents market share by type.
Cobalt-chromium alloys dominate the metal stents market growth in terms of material.
Polymer-free coatings are the most preferred coating material in the metal stents market size.
Balloon-expandable stents dominate the metal stents market share by mechanism.
Coronary stents are the leading application segment in the metal stents market growth.
Hospitals serve as the primary end users in the metal stents market size.
North America is dominating region in the metal stent market share.
The Asia Pacific region is seeing the fastest growth in the metal stent market.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Bioresorbable and polymer-free coating technologies	Cyber-security and patient data privacy	Self-expanding and polymer-free stents

Key Highlights:

In 2024, scientists from the Korea Institute of Science and Technology (KIST) developed a laser patterning technique that produces nano- and micro-wrinkles on nickel-titanium alloy stents, dramatically improving vascular healing. The surface technology increased endothelial cell development by 250 percent while decreasing smooth muscle proliferation by three-quarters, which was a significant drawback of drug-eluting stents, including delayed healing and the risk of thrombosis.

Report Analysis:

Developments in biodegradable stents:

One of the milestones in the technology of vascular intervention is the availability of the biodegradable stents that have a benefit of scaffolding the vessel, and as they dissolve in the body. There has been a recent thrust on bio-degradable metal stents-largely composed of magnesium and iron alloys that not only offer the required mechanical support during the important healing stages but also subsequently degrade safely beyond that with fewer long-term morbidities related to permanent metallic implants.

There are new technologies such as bioresorbable covering, hybrid metal-polymer composites and tailor-textured designs to maximize the rate of degradation and mechanical properties. These stents reduce the risks of late thrombosis, chronic inflammation and restenosis which are popular with permanent stents.

Browse ∼60 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Metal Stents Market Size, Share, By Type [(Bare Metal Stents (BMS), Drug-Eluting Stents (DES), Grafted Stents and others)], Material [(Stainless Steel, Cobalt-Chromium Alloy, Platinum-Chromium Alloy, Nitinol (Nickel-Titanium Alloy), and Others)], Coating material [(Biodegradable, Durable polymers, Polymer-Free, Dual-Drug Coatings and Others), Mechanism [(Balloon-Expandable, Self-Expanding, and Hybrid (Partially Self-Expanding)], Application (Coronary Stents, Peripheral Vascular Stents, Carotid Stents, Renal Artery Stents, Aortic Stents, and Others), End User (Hospitals, Cardiac Catheterization Labs, Outpatient Surgery Centers, and Others) and Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Type:

Bare Metal Stents (BMS)
Drug-Eluting Stents (DES)
Grafted Stents
Others

By Material:

Stainless Steel
Cobalt-Chromium Alloy
Platinum-Chromium Alloy
Nitinol (Nickel-Titanium Alloy)
Others

By Coating material:

Biodegradable
Durable polymers
Polymer-free
Dual-drug coatings
Others

By Mechanism:

Balloon-Expandable
Self-Expanding
Hybrid

By Application:

Coronary Stents
Peripheral Vascular Stents
Carotid Stents
Renal Artery Stents
Aortic Stents
Others

By End Users:

Hospitals
Cardiac Catheterization Labs
Outpatient Surgery Centers
Others

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa

For more insights into the Metal Stent Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/Global-Metal-Stents-Market-By-2545

Competitive Landscape of Metal Stent Market:

The key players operating in the metal stent market include Abbott, optimied Medizinische Instrumente GmbH, ELLA – CS, s.r.o., Eurocor Tech GmbH, Alvimedica, Cook, MicroPort Scientific Corporation, Meril Life Sciences, SCITECH, B. Braun SE, Lepu Medical Technology (Beijing)Co.,Ltd., MICRO-TECH (Nanjing) Co., Ltd., Johnson & Johnson, Terumo Europe NV, and Boston Scientific Corporation